Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation

scientific article

Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0735-1097(03)00953-7
P698PubMed publication ID14522490

P50authorHartzell V. SchaffQ37829966
P2093author name stringMary Howard
Douglas L Packer
John A Odell
Christopher Stone
Joseph L Blackshear
Lesly Pearce
Vickie S Baker
W Dudley Johnson
P2860cites workFactors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) InvestigatorsQ33863941
The left atrial appendage: our most lethal human attachment! Surgical implicationsQ33905940
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experienceQ34127331
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationQ34372459
Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction?Q40952216
Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.Q53347704
Impact of the maze procedure on the stroke rate in patients with atrial fibrillationQ61648622
Atrial fibrillation and stroke. Revisiting the dilemmasQ72041652
Stroke after coronary artery bypass: incidence, predictors, and clinical outcomeQ74148161
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectatrial fibrillationQ815819
P304page(s)1249-1252
P577publication date2003-10-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleThoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation
P478volume42

Reverse relations

cites work (P2860)
Q22306351ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Q56607936Atrial fibrillation
Q28201536Atrial fibrillation and stroke prevention
Q28222928Atrial fibrillation and stroke prevention
Q34423822Cardiac imaging for assessment of left atrial appendage stasis and thrombosis.
Q37464600Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage
Q33162506Catheter ablation in combination with left atrial appendage closure for atrial fibrillation
Q53247175Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
Q41640481Concomitant Left Atrial Appendage Clipping During Minimally Invasive Mitral Valve Surgery: Technically Feasible and Safe
Q35648223Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation
Q36087921Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation
Q37859753Future epidemic impact of atrial fibrillation and a new interventional strategy for stroke prophylaxis
Q47211007Innovation focus: the patient with arrhythmia
Q38630969Interventional and surgical occlusion of the left atrial appendage
Q47159202Leaks after left atrial appendage ligation with Lariat device: Incidence, pathophysiology, clinical implications and methods of closure- A case based discussion
Q37764740Left atrial appendage closure
Q27001220Left atrial appendage closure devices
Q36891886Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges
Q40244130Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery
Q35691402Left atrial appendage exclusion for atrial fibrillation
Q38177227Left atrial appendage exclusion for prevention of stroke in atrial fibrillation: review of minimally invasive approaches
Q26851429Left atrial appendage exclusion-Where do we stand?
Q37678317Left atrial appendage exclusion: state-of-the-art.
Q39570419Left atrial appendage occlusion and ligation devices: what is available, how to implement them, and how to manage and avoid complications.
Q41356789Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis
Q37632397Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation
Q37977275New frontiers for stroke prevention in atrial fibrillation.
Q37931364Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation
Q36216812Nonpharmacologic stroke prevention in atrial fibrillation
Q39178470Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
Q79106873Obliteration of the left atrial appendage for prevention of thromboembolism
Q48339574Percutaneous epicardial left atrial appendage closure: intermediate-term results
Q45190841Percutaneous left atrial appendage transcatheter occlusion for patients with atrial fibrillation unable to take warfarin
Q37997507Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation
Q44279015Role of video-assisted thoracoscopy in the management of stroke
Q43774366Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices
Q52148993Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation.
Q35989632Stroke prevention in atrial fibrillation: warfarin faces its challengers
Q38075000Surgical strategies and devices for surgical exclusion of the left atrial appendage: a word of caution
Q47336294Surgical techniques for left atrial appendage exclusion
Q51353811The left atrial appendage: from embryology to prevention of thromboembolism.
Q83291171[Techniques for occlusion of the left atrial appendage: chances and risks]

Search more.